About
William Greene, M.D., joined MPM in 2002 and has led investments in biopharmaceuticals, medical devices and pharma services. Bill is currently serving as CEO of MPM portfolio company Iconic Therapeutics, Inc., which is developing novel therapeutics for ophthalmologic diseases and cancer. He currently also sits on the Board of Sai Advantium Pharma. Bill’s Board and investment experience includes Alnara (acquired by Eli Lilly:LLY), Alsius (Acquired, Zoll), Barrier Therapeutics (BTRX), Cotherix (CTRX), Idun Pharmaceuticals (acquired by Pfizer:PFE), and Intercell AG (ICLL, Vienna Stock Exchange). In addition to investing and serving on corporate boards, Bill has filled roles with portfolio companies including interim VP of Regulatory Affairs, Chief Medical Officer and Scientific and Clinical Development Advisory Boards. Prior to joining MPM, Bill was at Genentech (acquired by Roche:RHHBY) where he served as a Senior Clinical Scientist and Epidemiologist with responsibilities in clinical
Position in the VCSift Database
- • 1 investors hold the Chariman and CEO role in VCSift. William Greene is one of them.
- • 7,285 investors are based in San Francisco, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Francisco, US
Contact Information
Find more investors like William
Search Investors